Jefferies Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jefferies Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-175,599	Closed	-$33.2M	–	1848
2026 Q1	$33.2M	Buy	175,599 +172,099	+4,917%	+$30.1M	0.23%	75
2025 Q4	$595K	Buy	+3,500	New	+$537K	﹤0.01%	1278
2025 Q2	–	Sell	-11,213	Closed	-$1.39M	–	1569
2025 Q1	$1.39M	Buy	+11,213	New	+$1.46M	0.01%	683
2024 Q2	–	Sell	-46,662	Closed	-$5.62M	–	1630
2024 Q1	$5.62M	Sell	46,662 -3,815	-8%	-$467K	0.05%	287
2023 Q4	$6.21M	Buy	50,477 +48,001	+1,939%	+$5.99M	0.04%	336
2023 Q3	$320K	Buy	+2,476	New	+$330K	﹤0.01%	1211

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Jefferies Financial Group's JAZZ Position: Q2 2026 in Review

Jefferies Financial Group sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 175,599 shares — an estimated $33.2M sold.

Jefferies Financial Group first reported a position in JAZZ in Q3 2023 and held it in 6 quarters. The position peaked at $33.2M in Q1 2026. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Jefferies Financial Group reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jefferies Financial Group sold 175,599 Jazz Pharmaceuticals shares in Q2 2026, an estimated $33.2M.
Jefferies Financial Group first reported a position in Jazz Pharmaceuticals in Q3 2023 and held it in 6 quarters.
Jefferies Financial Group's Jazz Pharmaceuticals position peaked at $33.2M in Q1 2026.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.